535 related articles for article (PubMed ID: 14655910)
41. Eszopiclone for insomnia.
Melton ST; Wood JM; Kirkwood CK
Ann Pharmacother; 2005 Oct; 39(10):1659-66. PubMed ID: 16131537
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
Mayer G; Wang-Weigand S; Roth-Schechter B; Lehmann R; Staner C; Partinen M
Sleep; 2009 Mar; 32(3):351-60. PubMed ID: 19294955
[TBL] [Abstract][Full Text] [Related]
43. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
44. Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs.
McCall WV; D'Agostino R; Rosenquist PB; Kimball J; Boggs N; Lasater B; Blocker J
Sleep Med; 2011 Jun; 12(6):557-64. PubMed ID: 21601519
[TBL] [Abstract][Full Text] [Related]
45. Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial.
Gross CR; Kreitzer MJ; Reilly-Spong M; Wall M; Winbush NY; Patterson R; Mahowald M; Cramer-Bornemann M
Explore (NY); 2011; 7(2):76-87. PubMed ID: 21397868
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.
Snedecor SJ; Botteman MF; Bojke C; Schaefer K; Barry N; Pickard AS
Sleep; 2009 Jun; 32(6):817-24. PubMed ID: 19544759
[TBL] [Abstract][Full Text] [Related]
47. Eszopiclone: a review of its use in the treatment of insomnia.
Hair PI; McCormack PL; Curran MP
Drugs; 2008; 68(10):1415-34. PubMed ID: 18578559
[TBL] [Abstract][Full Text] [Related]
48. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
49. APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia.
Rosenberg R; Seiden DJ; Hull SG; Erman M; Schwartz H; Anderson C; Prosser W; Shanahan W; Sanchez M; Chuang E; Roth T
Sleep; 2008 Dec; 31(12):1663-71. PubMed ID: 19090322
[TBL] [Abstract][Full Text] [Related]
50. Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial.
Jakobsen G; Engstrøm M; Paulsen Ø; Sjue K; Raj SX; Thronæs M; Hjermstad MJ; Kaasa S; Fayers P; Klepstad P
Trials; 2018 Dec; 19(1):707. PubMed ID: 30591073
[TBL] [Abstract][Full Text] [Related]
51. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.
Sivertsen B; Omvik S; Pallesen S; Bjorvatn B; Havik OE; Kvale G; Nielsen GH; Nordhus IH
JAMA; 2006 Jun; 295(24):2851-8. PubMed ID: 16804151
[TBL] [Abstract][Full Text] [Related]
52. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
53. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
54. Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial.
Lettieri CJ; Quast TN; Eliasson AH; Andrada T
Sleep; 2008 Sep; 31(9):1310-6. PubMed ID: 18788656
[TBL] [Abstract][Full Text] [Related]
55. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
[TBL] [Abstract][Full Text] [Related]
56. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
Zammit G; Erman M; Wang-Weigand S; Sainati S; Zhang J; Roth T
J Clin Sleep Med; 2007 Aug; 3(5):495-504. PubMed ID: 17803013
[TBL] [Abstract][Full Text] [Related]
58. Eszopiclone for late-life insomnia.
McCrae CS; Ross A; Stripling A; Dautovich ND
Clin Interv Aging; 2007; 2(3):313-26. PubMed ID: 18044182
[TBL] [Abstract][Full Text] [Related]
59. The role of eszopiclone in the treatment of insomnia.
Morin AK; Willett K
Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
[TBL] [Abstract][Full Text] [Related]
60. Sedative use during continuous positive airway pressure titration improves subsequent compliance: a randomized, double-blind, placebo-controlled trial.
Lettieri CJ; Collen JF; Eliasson AH; Quast TM
Chest; 2009 Nov; 136(5):1263-1268. PubMed ID: 19567493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
